Free Normetanephrines

If you have had spells of pounding heart, sweating, flushing, or blood pressure that will not come down on standard medications, your doctor may want to rule out a rare but serious tumor called a pheochromocytoma or paraganglioma (often shortened to PPGL). Free normetanephrine is one of the most accurate blood tests for catching these tumors, and it can do so before the tumor grows large or spreads.

The test is not a routine screen for otherwise healthy people. It is a targeted workup for specific situations: unexplained symptoms, an adrenal mass found on imaging, a family history of these tumors, or a known genetic risk. When used in the right setting, it is one of the most sensitive biochemical tests in all of endocrinology.

What This Test Actually Measures

Free normetanephrine is a breakdown product of norepinephrine, the hormone your body releases during fight-or-flight moments. A small amount is always circulating. When a pheochromocytoma or paraganglioma is present, the tumor pumps out norepinephrine continuously, and the free normetanephrine level in blood rises far above normal.

The word "free" matters. Most normetanephrine in your body is chemically attached to a sulfate group, which masks it. The free version is the small, unattached fraction that most closely tracks what the adrenal gland or a tumor is actively secreting. Measuring the free form is more diagnostically useful than measuring the combined (deconjugated) form because it is less swayed by diet and gives a cleaner signal.

Why This Biomarker Matters

Pheochromocytomas and paragangliomas are rare, but when they are missed, they can cause sudden strokes, heart attacks, or dangerous blood pressure swings during surgery or childbirth. Because the symptoms overlap with anxiety, panic attacks, and essential hypertension, these tumors are often diagnosed late. A sensitive blood test that reliably flags them shifts the odds of catching the tumor early, when it is almost always curable with surgery.

Catecholamine-Producing Tumors

Free normetanephrine is the single most informative marker for detecting a pheochromocytoma (a tumor of the adrenal gland) or a paraganglioma (a related tumor found elsewhere in the body). In a meta-analysis, plasma free normetanephrine alone delivered roughly 97% sensitivity and 93% specificity for detecting these tumors. In large prospective studies, the combined plasma panel of free normetanephrine and metanephrine reached sensitivity above 95% and specificity above 90%, meaning it catches nearly every tumor while rarely misfiring.

The level you see on your report can also carry clues about the tumor itself. Patterns of normetanephrine, metanephrine, and a related metabolite called 3-methoxytyramine can predict tumor size, whether it sits inside or outside the adrenal gland, and even the likely genetic mutation driving it. That extra information helps guide imaging and genetic testing if the test is positive.

Hereditary Risk

About one in three PPGLs is caused by an inherited gene change, such as mutations in the SDHB or SDHD genes. If you have a known mutation or a close family member with one of these tumors, free normetanephrine testing is the first-line screen used to catch new tumors early. In high-risk patients (hereditary mutations, prior PPGL, or an adrenal mass found incidentally), plasma free metanephrines outperform urine-based tests.

Metabolic and Energy Effects

When a tumor produces large amounts of norepinephrine, the resulting free normetanephrine elevation reflects a body-wide state of catecholamine excess. In an observational study of PPGL patients, higher plasma normetanephrine was associated with activated brown fat, a heat-producing tissue that burns calories in response to sympathetic nerve signals. The brown fat activation did not clearly affect survival in this cohort, but the finding illustrates how systemic the hormonal effects of these tumors can be.

Reference Ranges

These ranges come from a validated liquid chromatography mass spectrometry method and reflect typical adult cutoffs reported in research. They are illustrative orientation, not a universal target. Your lab will report its own reference interval, often with different units, and the cutoff is age-adjusted: older adults have higher baseline values. Compare your result against your own lab's reference range, and compare serial results within the same lab for the most meaningful trend.

Source: reference intervals derived from Eisenhofer et al. 2013 and Huang et al. 2017, with interpretation tiers from Eisenhofer et al. 2003 and the 2014 Endocrine Society clinical practice guideline.

When Results Can Be Misleading

Free normetanephrine is very sensitive, which means it can be triggered by things other than a tumor. Understanding the common distorters is the difference between a useful result and an unnecessary imaging scan.

• Sampling position and setting: Outpatient seated sampling produces substantially higher plasma free normetanephrine values than inpatient supine sampling and roughly triples the false-positive rate. Semi-recumbent posture gives values higher than fully supine. A cold room pushes outpatient values higher still.
• Medications that raise the number: Tricyclic antidepressants and phenoxybenzamine can roughly double plasma normetanephrine and account for a large share of false-positive elevations in people without tumors. Sympathomimetics (pseudoephedrine, caffeine, amphetamines, nicotine, cocaine) and MAO inhibitors can also push the number up.
• Assay interference: Sulfasalazine, acetaminophen, mesalamine, labetalol, sotalol, methyldopa, and midodrine can falsely elevate urinary normetanephrine in older HPLC-based assays. A confirmatory run on a mass spectrometry method usually clears this up.
• Kidney disease and severe illness: Chronic kidney disease stages 3 to 4 and dialysis raise plasma free metanephrines and require kidney-specific reference intervals. ICU-level illness, acute anxiety, and untreated sleep apnea can all push values into the abnormal range without any tumor present.

Tracking Your Trend

For most people, this is not a test you repeat every year out of curiosity. The value of serial testing lies in two specific situations. First, if you have a known genetic mutation (such as SDHB or SDHD) or have had a PPGL removed, lifetime annual monitoring is standard, because new or recurrent tumors can appear years later. Second, if your first result was borderline, a repeat test under strictly controlled conditions (supine rest for at least 30 minutes, no interfering medications, no caffeine) is the fastest way to separate a true positive from a false alarm.

Because sampling posture, setting, and medications can shift the number so much, comparing your results within the same lab under the same conditions is far more informative than comparing absolute numbers across labs. Studies show meaningful disagreement in interpretation between labs even when the underlying mass spectrometry method is the same, mostly because reference intervals are not harmonized.

What to Do If Your Result Is Abnormal

An abnormal free normetanephrine is the start of a workup, not a diagnosis. The degree of elevation matters. A value in the gray zone (mild elevation, up to around 400 ng/L) is usually a false positive, and the first step is to repeat the test after removing interfering medications, ensuring supine rest, and ruling out acute stress or illness. A value more than three times the upper limit, especially paired with an elevated metanephrine, is rarely a false positive and almost always prompts imaging.

If repeat testing confirms the elevation, the usual next steps are imaging of the adrenal glands and abdomen (CT or MRI), consultation with an endocrinologist, and genetic testing if the pattern suggests a hereditary syndrome. Chromogranin A and plasma methoxytyramine can be ordered alongside to help characterize the tumor type. Surgery, performed after careful preoperative blockade, is curative in most cases.